CCMINC
UTMD icon

Cardinal Capital Management Inc (North Carolina)’s Utah Medical Products UTMD Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Buy
27,094
+551
+2% +$36.6K 0.23% 113
2026
Q1 		$1.65M Buy
26,543
+1,707
+7% +$108K 0.21% 109
2025
Q4 		$1.39M Buy
24,836
+459
+2% +$26.6K 0.18% 118
2025
Q3 		$1.54M Buy
24,377
+1,597
+7% +$94.5K 0.21% 112
2025
Q2 		$1.3M Buy
22,780
+912
+4% +$49.6K 0.19% 118
2025
Q1 		$1.23M Buy
21,868
+2,084
+11% +$125K 0.19% 118
2024
Q4 		$1.22M Buy
19,784
+1,336
+7% +$86.4K 0.19% 117
2024
Q3 		$1.24M Buy
18,448
+2,803
+18% +$190K 0.19% 117
2024
Q2 		$1.05M Buy
15,645
+908
+6% +$61.8K 0.18% 117
2024
Q1 		$1.05M Buy
14,737
+3,010
+26% +$226K 0.17% 123
2023
Q4 		$991K Buy
11,727
+146
+1% +$12.1K 0.19% 115
2023
Q3 		$999K Buy
11,581
+272
+2% +$25.1K 0.2% 112
2023
Q2 		$1.06M Buy
11,309
+143
+1% +$13.5K 0.21% 107
2023
Q1 		$1.06M Buy
11,166
+30
+0.3% +$2.76K 0.22% 103
2022
Q4 		$1.12M Buy
11,136
+139
+1% +$12.7K 0.24% 104
2022
Q3 		$938K Buy
10,997
+194
+2% +$17.1K 0.22% 104
2022
Q2 		$928K Buy
10,803
+219
+2% +$18.7K 0.21% 109
2022
Q1 		$951K Buy
10,584
+487
+5% +$44.8K 0.19% 114
2021
Q4 		$1.01M Buy
10,097
+4
+0% +$408 0.2% 110
2021
Q3 		$937K Buy
10,093
+68
+0.7% +$6.01K 0.2% 111
2021
Q2 		$853K Buy
10,025
+47
+0.5% +$4.07K 0.18% 117
2021
Q1 		$864K Buy
9,978
+168
+2% +$14.8K 0.19% 116
2020
Q4 		$827K Buy
9,810
+239
+2% +$20.4K 0.2% 111
2020
Q3 		$764K Buy
9,571
+299
+3% +$24.8K 0.21% 102
2020
Q2 		$821K Sell
9,272
-998
-10% -$89.6K 0.24% 98
2020
Q1 		$965K Buy
10,270
+576
+6% +$53.5K 0.32% 80
2019
Q4 		$1.05M Sell
9,694
-135
-1% -$13.7K 0.27% 95
2019
Q3 		$942K Sell
9,829
-95
-1% -$8.83K 0.26% 95
2019
Q2 		$950K Sell
9,924
-239
-2% -$20.1K 0.27% 95
2019
Q1 		$896K Buy
10,163
+123
+1% +$10.8K 0.26% 97
2018
Q4 		$834K Buy
10,040
+192
+2% +$16.9K 0.27% 92
2018
Q3 		$927K Buy
9,848
+13
+0.1% +$1.24K 0.26% 98
2018
Q2 		$1.08M Buy
9,835
+33
+0.3% +$3.45K 0.33% 88
2018
Q1 		$968K Sell
9,802
-98
-1% -$8.74K 0.3% 91
2017
Q4 		$806K Sell
9,900
-62
-0.6% -$4.84K 0.24% 96
2017
Q3 		$732K Buy
9,962
+782
+9% +$56.2K 0.23% 99
2017
Q2 		$665K Buy
9,180
+1,235
+16% +$81.3K 0.22% 98
2017
Q1 		$495K Buy
7,945
+103
+1% +$6.48K 0.18% 103
2016
Q4 		$571K Buy
7,842
+972
+14% +$63.2K 0.22% 96
2016
Q3 		$411K Buy
6,870
+558
+9% +$35.5K 0.16% 100
2016
Q2 		$398K Buy
6,312
+323
+5% +$20.8K 0.16% 101
2016
Q1 		$375K Buy
5,989
+421
+8% +$24.8K 0.16% 104
2015
Q4 		$326K Buy
5,568
+231
+4% +$13.1K 0.15% 103
2015
Q3 		$288K Buy
5,337
+693
+15% +$37.8K 0.13% 104
2015
Q2 		$277K Buy
4,644
+896
+24% +$50.4K 0.12% 108
2015
Q1 		$224K Buy
+3,748
New +$220K 0.09% 117

Other funds holding UTMD

EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.42B AUM 22.12% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
PIM
Penobscot Investment Management Boston, Massachusetts $1.46B AUM 32.32% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s UTMD Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its Utah Medical Products (UTMD) stake by 2.1% in Q2 2026, buying an estimated $36.6K and bringing the position to 27,094 shares worth $1.88M. The position accounts for 0.23% of the portfolio, ranked #113.

Cardinal Capital Management Inc (North Carolina) first reported a position in UTMD in Q1 2015 and has held it in 46 quarters since. 30 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 27,094 shares of Utah Medical Products worth $1.88M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) bought 551 Utah Medical Products shares in Q2 2026, an estimated $36.6K.
  • Utah Medical Products made up 0.23% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #113 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Utah Medical Products in Q1 2015 and has held it in 46 quarters since.
  • 30 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.